ATS-8535

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameATS-8535
Drug Alias NameATS-8535
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 2 inhibitorsRho-associated protein kinase 1 inhibitors
TargetsRho-associated protein kinase 1Rho-associated protein kinase 2
Therapy Area/IndicationsGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAsahi Kasei Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltheos IncAsahi Kasei Corp
Active IndicationsN/A
Inactive IndicationsGlaucomaOcular Hypertension

Other Information

ATC CodeN/A
Related LinksN/A